SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 31 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2022$259,000
-12.2%
181,1690.0%0.01%
-37.5%
Q4 2021$295,000
+35.9%
181,169
+166.0%
0.01%
+100.0%
Q3 2021$217,00068,1000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 373,867$1,847,0000.43%
NewGen Asset Management Ltd 200,000$988,0000.37%
SABBY MANAGEMENT, LLC 174,900$864,0000.12%
Kepos Capital LP 100,000$494,0000.04%
Hudson Bay Capital Management LP 380,404$1,879,0000.02%
Paloma Partners Management Co 139,081$687,0000.01%
Cutler Group LLC / CA 24,495$121,0000.01%
Cutler Group LLC / CA 35,000$36,0000.00%
Stratos Wealth Partners, LTD. 15,543$77,0000.00%
Lake Point Wealth Management 1,000$5,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders